| Glial cells in adult neurogenesis J Morrens, W Van Den Broeck, G Kempermann Glia 60 (2), 159-174, 2012 | 187 | 2012 |
| Cue-evoked dopamine promotes conditioned responding during learning J Morrens, Ç Aydin, AJ van Rensburg, JE Rabell, S Haesler Neuron 106 (1), 142-153. e7, 2020 | 95 | 2020 |
| Real-world evidence from a European cohort study of patients with treatment resistant depression: treatment patterns and clinical outcomes K Heerlein, G Perugi, C Otte, T Frodl, G Degraeve, W Hagedoorn, ... Journal of Affective Disorders 290, 334-344, 2021 | 45 | 2021 |
| Real-world evidence from a European cohort study of patients with treatment resistant depression: baseline patient characteristics K Heerlein, AH Young, C Otte, T Frodl, G Degraeve, W Hagedoorn, ... Journal of Affective Disorders 283, 115-122, 2021 | 31 | 2021 |
| Real-world evidence from a European cohort study of patients with treatment resistant depression: healthcare resource utilization K Heerlein, S De Giorgi, G Degraeve, T Frodl, W Hagedoorn, ... Journal of Affective Disorders 298, 442-450, 2022 | 15 | 2022 |
| Dopamine neurons coding prediction errors in reward space, but not in aversive space: a matter of location? J Morrens Journal of Neurophysiology 112 (5), 1021-1024, 2014 | 6 | 2014 |
| Use of Clinical Global Impressions-Severity (CGI-S) to assess response to antidepressant treatment in patients with treatment-resistant depression J Morrens, M Mathews, V Popova, S Borentain, B Rive, BGM Moro, ... Neuropsychiatric Disease and Treatment 18, 1127, 2022 | 5 | 2022 |
| Simultaneous measurement of glomerular filtration rate, effective renal plasma flow and tubular secretion in different poultry species by single intravenous bolus of iohexol … L Stroobant, S Croubels, L Dhondt, J Millecam, S De Baere, E Gasthuys, ... Animals 10 (6), 1027, 2020 | 5 | 2020 |
| Clinical features and outcomes of 124 Italian patients with treatment resistant depression: a real-world, prospective study G Perugi, P Calò, S De Filippis, G Rosso, A Vita, M Adami, G Ascione, ... Frontiers in Psychiatry 12, 769693, 2021 | 4 | 2021 |
| Development of an in vivo lipopolysaccharide inflammation model to study the pharmacodynamics of COX-2 inhibitors celecoxib, mavacoxib, and meloxicam in cockatiels (Nymphicus … E Gasthuys, R Houben, R Haesendonck, S De Baere, SU Sys, J Morrens, ... Journal of avian medicine and surgery 33 (4), 349-360, 2019 | 4 | 2019 |
| ICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression … AJ Oliveira-Maia, J Morrens, B Rive, Y Godinov, J Cabrieto, N Perualila, ... Frontiers in Psychiatry 14, 1250980, 2023 | 1 | 2023 |
| Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant … AJ Oliveira-Maia, B Rive, J Morrens, Y Godinov, J Cabrieto, N Perualila, ... Frontiers in Psychiatry 14, 1250987, 2023 | 1 | 2023 |
| PMH44 Increased use of augmentation therapies illustrates complex management of treatment resistant depression. Preliminary results from a real-word evidence registry in Europe … J Morrens, B Rive, G VanDooren, D Umuhire, S Malynn Value in Health 22, S688, 2019 | 1 | 2019 |
| Microscopische analyse van astrocyten ter hoogte van de dentate gyrus J Morrens, W Van den Broeck Masterproef Universiteit Gent, België, 2010 | 1 | 2010 |
| Invloed van het micromilieu op de adulte neurogenese ter hoogte van de hippocampus J MORRENS, W Van den Broeck Masterproef faculteit diergeneeskunde, Universiteit Gent, 2008 | 1 | 2008 |
| 40351 Disease severity in moderate-to-severe plaque psoriasis: results from the Belgian REDISCOVER study T Hillary, L Ghys, F Willaert, S Swimberghe, M Lecuyer, PD Ghislain, ... Journal of the American Academy of Dermatology 89 (3), AB37, 2023 | | 2023 |
| CO151 Estimating the Benefit of Esketamine Nasal Spray Versus Real-World Treatment on Patient-Reported Functional Remission: Results From the Iceberg Study A Oliveira-Maia, B Rive, J Morrens, Y Godinov, S Mulhern-Haughey Value in Health 25 (12), S47, 2022 | | 2022 |
| P. 0225 Indirect comparison estimating the benefit of esketamine compared to real-world treatment of treatment resistant depression in general psychiatry: preliminary analysis J Morrens, AJ Oliveira-Maia, B Falissard, SM Haughey, S Barbreau, ... European Neuropsychopharmacology 53, S162-S163, 2021 | | 2021 |
| P. 0226 Indirect comparison estimating the benefit of esketamine compared to distinct real-world treatment strategies for treatment resistant depression in general psychiatry B Rive, AJ Oliveira-Maia, B Falissard, SM Haughey, S Barbreau, ... European Neuropsychopharmacology 53, S163-S165, 2021 | | 2021 |
| P. 0099 Treatment resistant depression in Spain: sub-analysis from a European real-world evidence study E Baca-García, V Pérez-Sola, PS San Miguel, J Morrens, CP Rivero, ... European Neuropsychopharmacology 53, S71-S72, 2021 | | 2021 |
